CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Financial Officer Atabak Mokari sold $3.2M of Corcept Therapeutics Incorporated
Sold$3,245,900
$81.15Price
40,000Shares
−71%Stake
What CORT did after the filing
- The stock from Thu, Jun 18 open, $82.82
- +36.2%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Aug 3 close.
Traded Mon, Jun 15. Filed Wed, Jun 17, 4:30 PM ET, after the close. Returns use the Jun 18 open and the Aug 3 close. Not investment advice.